View in EDS

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.

Saved in:
Bibliographic Details
Title: TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
Authors: Pfeiffer, Per1,2 (AUTHOR) per.pfeiffer@rsyd.dk, Yilmaz, Mette3 (AUTHOR), Möller, Sören2,4 (AUTHOR), Zitnjak, Daniela5 (AUTHOR), Krogh, Merete1 (AUTHOR), Petersen, Lone Nørgård6 (AUTHOR), Poulsen, Laurids Østergaard3 (AUTHOR), Winther, Stine Braendegaard1 (AUTHOR), Thomsen, Karina Gravgaard1 (AUTHOR), Qvortrup, Camilla6 (AUTHOR)
Source: Lancet Oncology. Mar2020, Vol. 21 Issue 3, p412-420. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 142004205
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Pfeiffer%2C+Per%22">Pfeiffer, Per</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> per.pfeiffer@rsyd.dk</i><br /><searchLink fieldCode="AR" term="%22Yilmaz%2C+Mette%22">Yilmaz, Mette</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Möller%2C+Sören%22">Möller, Sören</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zitnjak%2C+Daniela%22">Zitnjak, Daniela</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krogh%2C+Merete%22">Krogh, Merete</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Petersen%2C+Lone+Nørgård%22">Petersen, Lone Nørgård</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Poulsen%2C+Laurids+Østergaard%22">Poulsen, Laurids Østergaard</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Winther%2C+Stine+Braendegaard%22">Winther, Stine Braendegaard</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thomsen%2C+Karina+Gravgaard%22">Thomsen, Karina Gravgaard</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qvortrup%2C+Camilla%22">Qvortrup, Camilla</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Mar2020, Vol. 21 Issue 3, p412-420. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=142004205
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(19)30827-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 412
    Titles:
      – TitleFull: TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pfeiffer, Per
      – PersonEntity:
          Name:
            NameFull: Yilmaz, Mette
      – PersonEntity:
          Name:
            NameFull: Möller, Sören
      – PersonEntity:
          Name:
            NameFull: Zitnjak, Daniela
      – PersonEntity:
          Name:
            NameFull: Krogh, Merete
      – PersonEntity:
          Name:
            NameFull: Petersen, Lone Nørgård
      – PersonEntity:
          Name:
            NameFull: Poulsen, Laurids Østergaard
      – PersonEntity:
          Name:
            NameFull: Winther, Stine Braendegaard
      – PersonEntity:
          Name:
            NameFull: Thomsen, Karina Gravgaard
      – PersonEntity:
          Name:
            NameFull: Qvortrup, Camilla
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1